Xeris Pharmaceuticals Inc Earnings

The next earnings date for Xeris Pharmaceuticals Inc is November 6, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Xeris Pharmaceuticals Inc Earnings

Report Date	Estimated Earnings Per Share
11/06/2025	$0.01

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Xeris Pharmaceuticals Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/07/2025	---	$-0.01	66.67%
05/08/2025	Before Market	$-0.06	-50.00%
03/04/2025	Before Market	$-0.03	-50.00%
11/08/2024	Before Market	$-0.11	-22.22%
08/08/2024	Before Market	$-0.10	9.09%
05/09/2024	Before Market	$-0.14	-16.67%
03/06/2024	Before Market	$-0.10	0.00%
11/09/2023	Before Market	$-0.09	25.00%
08/08/2023	Before Market	$-0.14	-7.69%
05/09/2023	Before Market	$-0.12	29.41%
03/08/2023	Before Market	$-0.10	37.50%
11/09/2022	Before Market	$-0.16	0.00%
08/10/2022	Before Market	$-0.19	17.39%
05/11/2022	Before Market	$-0.25	0.00%
03/10/2022	Before Market	$-0.42	-75.00%
11/10/2021	Before Market	$-0.39	-5.41%
08/05/2021	Before Market	$-0.41	-36.67%
05/13/2021	Before Market	$-0.30	11.76%
03/09/2021	Before Market	$-0.41	-7.89%
11/09/2020	Before Market	$-0.35	32.69%
08/10/2020	Before Market	$-0.63	13.70%
05/07/2020	Before Market	$-0.89	0.00%
03/11/2020	Before Market	$-1.23	-8.85%
11/07/2019	Before Market	$-1.22	0.81%
08/06/2019	After Market	$-1.28	-36.17%
05/09/2019	After Market	$-1.07	-40.79%
03/06/2019	After Market	$-0.98	-5.38%
11/07/2018	Before Market	$-0.71	8.97%
08/13/2018	Before Market	$-3.07	-248.86%
06/21/2018	After Market	$-4.69	---
02/03/2018	---	$-1.29	---
12/31/2017	---	$-4.43	---
09/30/2017	---	$-3.72	---
05/04/2017	---	$-0.23	---
03/31/2017	---	$-2.29	---

More About Xeris Pharmaceuticals Inc

Website

https://www.xerispharma.com

Country

USA

Full Time Employees

394

Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.

“Xeris Pharmaceuticals Inc Earnings” Can Refer to the Xeris Pharmaceuticals Inc Earnings Date

Some people say “Xeris Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Xeris Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Xeris Pharmaceuticals Inc Stock on the Earnings Date

If you own Xeris Pharmaceuticals Inc stock (XERS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Xeris Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Xeris Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Xeris Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Xeris Pharmaceuticals Inc earnings or anything else related to the stock market.